Palatini, P <br/><br/>
Maintenance of blood-pressure-lowering effect following a missed dose of aliskiren, irbesartan or ramipril: results of a randomized, double-blind study.  [electronic resource] 

 -  Journal of human hypertension  Feb 2010 
 - 93-103 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5527 
<br/><br/><label>Standard No.: </label>10.1038/jhh.2009.38  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Amides--administration & dosage<br/>Angiotensin II Type 1 Receptor Blockers--administration & dosage<br/>Angiotensin-Converting Enzyme Inhibitors--administration & dosage<br/>Antihypertensive Agents--administration & dosage<br/>Biphenyl Compounds--administration & dosage<br/>Blood Pressure--drug effects<br/>Blood Pressure Monitoring, Ambulatory<br/>Brazil<br/>Canada<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Europe<br/>Female<br/>Fumarates--administration & dosage<br/>Humans<br/>Hypertension--drug therapy<br/>Irbesartan<br/>Male<br/>Medication Adherence<br/>Middle Aged<br/>Ramipril--administration & dosage<br/>Tetrazoles--administration & dosage<br/>Time Factors<br/>Treatment Outcome